Mount Sinai Launches Adams Valve Institute for Advanced Heart Care

Why It Matters

The institute consolidates world‑class expertise to improve survival for millions with valve disease while addressing inequities in diagnosis and treatment. Its research, education and policy work could reshape cardiovascular surgery standards globally.

Key Takeaways

• Institute unites multidisciplinary experts for valve disease innovation
• Focus on Ross procedure restores life expectancy without lifelong anticoagulation
• Centers target underserved populations and complex congenital conditions
• Global digital library provides free access to surgical videos
• Policy advocacy seeks licensing standards and better payer policies

Pulse Analysis

Valvular heart disease affects 8‑11 million Americans and contributes to roughly 30,000 deaths annually, yet diagnosis and treatment gaps persist, especially among minority groups and women. Mount Sinai has long been a national leader, performing the highest volume of mitral and tricuspid repairs and advanced aortic root surgeries in New York State. Leveraging two decades of surgical innovation under Dr. David H. Adams, the health system is now formalizing its expertise through the Adams Valve Institute, a dedicated hub designed to accelerate clinical outcomes and research across the full spectrum of valve pathology.

The institute will organize several Centers of Excellence that concentrate on high‑complexity and underserved valve conditions, from aortic disease and the Ross procedure to Marfan‑related connective‑tissue disorders and adult congenital defects. By integrating cardiologists, imaging specialists, anesthesiologists and scientists, the institute aims to refine reconstructive techniques and expand peer‑to‑peer education. A flagship component is the creation of the world’s largest digital library of valve‑reconstructive‑technique videos, freely available to surgeons worldwide, which promises to standardize best practices and accelerate skill transfer across institutions.

Beyond clinical care, the Adams Valve Institute will pursue policy advocacy aimed at harmonizing physician licensing, improving payer reimbursement and enhancing transparency in outcomes reporting. These efforts target systemic barriers that limit access for veterans, minorities and low‑income patients. By positioning itself as a global educational hub—offering live‑surgery courses, international missions and collaborative research—the institute not only reinforces Mount Sinai’s brand as a premier cardiovascular center but also sets a new benchmark for equitable, high‑quality valve surgery worldwide.